Open AccessAn Analysis of Extended Survival in Patients With Amyotrophic Lateral Sclerosis Treated With Riluzole
Author(s) -
Marc Rivière,
Vincent Meininger,
Phillipe Zeisser,
Theodore L. Munsat
Publication year - 1998
Publication title -
archives of neurology
Language(s) - English
Resource type - Journals
eISSN - 1538-3687
pISSN - 0003-9942
DOI - 10.1001/archneur.55.4.526
Subject(s) - riluzole , amyotrophic lateral sclerosis , placebo , medicine , randomization , subgroup analysis , clinical trial , anesthesia , disease , pathology , confidence interval , alternative medicine
In an attempt to better understand and define the progression of amyotrophic lateral sclerosis (ALS), we developed a classification of 5 discrete health states that reflect patients' activities of daily living. These health states were used to determine whether patients with ALS who are treated with riluzole differed from those treated with placebo.